Genetic Determinants of Serum Testosterone Concentrations in Men
Testosterone concentrations in men are associated with cardiovascular morbidity, osteoporosis, and mortality and are affected by age, smoking, and obesity. Because of serum testosterone's high heritability, we performed a meta-analysis of genome-wide association data in 8,938 men from seven cohorts and followed up the genome-wide significant findings in one in silico (n = 871) and two de novo replication cohorts (n = 4,620) to identify genetic loci significantly associated with serum testosterone concentration in men. All these loci were also associated with low serum testosterone concentration defined as <300 ng/dl. Two single-nucleotide polymorphisms at the sex hormone-binding globulin (SHBG) locus (17p13-p12) were identified as independently associated with serum testosterone concentration (rs12150660, p = 1.2×10−41 and rs6258, p = 2.3×10−22). Subjects with ≥3 risk alleles of these variants had 6.5-fold higher risk of having low serum testosterone than subjects with no risk allele. The rs5934505 polymorphism near FAM9B on the X chromosome was also associated with testosterone concentrations (p = 5.6×10−16). The rs6258 polymorphism in exon 4 of SHBG affected SHBG's affinity for binding testosterone and the measured free testosterone fraction (p<0.01). Genetic variants in the SHBG locus and on the X chromosome are associated with a substantial variation in testosterone concentrations and increased risk of low testosterone. rs6258 is the first reported SHBG polymorphism, which affects testosterone binding to SHBG and the free testosterone fraction and could therefore influence the calculation of free testosterone using law-of-mass-action equation.
Vyšlo v časopise:
Genetic Determinants of Serum Testosterone Concentrations in Men. PLoS Genet 7(10): e32767. doi:10.1371/journal.pgen.1002313
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002313
Souhrn
Testosterone concentrations in men are associated with cardiovascular morbidity, osteoporosis, and mortality and are affected by age, smoking, and obesity. Because of serum testosterone's high heritability, we performed a meta-analysis of genome-wide association data in 8,938 men from seven cohorts and followed up the genome-wide significant findings in one in silico (n = 871) and two de novo replication cohorts (n = 4,620) to identify genetic loci significantly associated with serum testosterone concentration in men. All these loci were also associated with low serum testosterone concentration defined as <300 ng/dl. Two single-nucleotide polymorphisms at the sex hormone-binding globulin (SHBG) locus (17p13-p12) were identified as independently associated with serum testosterone concentration (rs12150660, p = 1.2×10−41 and rs6258, p = 2.3×10−22). Subjects with ≥3 risk alleles of these variants had 6.5-fold higher risk of having low serum testosterone than subjects with no risk allele. The rs5934505 polymorphism near FAM9B on the X chromosome was also associated with testosterone concentrations (p = 5.6×10−16). The rs6258 polymorphism in exon 4 of SHBG affected SHBG's affinity for binding testosterone and the measured free testosterone fraction (p<0.01). Genetic variants in the SHBG locus and on the X chromosome are associated with a substantial variation in testosterone concentrations and increased risk of low testosterone. rs6258 is the first reported SHBG polymorphism, which affects testosterone binding to SHBG and the free testosterone fraction and could therefore influence the calculation of free testosterone using law-of-mass-action equation.
Zdroje
1. KaufmanJMVermeulenA 2005 The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26 833 876
2. HaringRVolzkeHFelixSBSchipfSDorrM 2009 Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 58 2027 2031
3. KupelianVPageSTAraujoABTravisonTGBremnerWJ 2006 Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91 843 850
4. HaringRBaumeisterSEVölzkeHDorrMFelixSB 2011 Prospective Association of Low Total Testosterone Concentrations with an Adverse Lipid Profile and Increased Incident Dyslipidemia. Eur J Cardiovasc Prev Rehabil 18 86 96
5. TorklerSWallaschofskiHBaumeisterSEVölzkeHDörrM 2011 Inverse Association Between Total Testosterone Concentrations, Incident Hypertension, and Blood Pressure. Aging Male 14 176 182
6. VikanTSchirmerHNjolstadISvartbergJ 2010 Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol 162 747 754
7. YeapBBHydeZAlmeidaOPNormanPEChubbSA 2009 Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab 94 2353 2359
8. SvartbergJvon MuhlenDMathiesenEJoakimsenOBonaaKH 2006 Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 259 576 582
9. VikanTJohnsenSHSchirmerHNjolstadISvartbergJ 2009 Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromso study. Eur J Epidemiol 24 289 295
10. TivestenAMellstromDJutbergerHFagerbergBLernfeltB 2007 Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden. J Am Coll Cardiol 50 1070 1076
11. HaringRVolzkeHStevelingAKrebsAFelixSB 2010 Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 31 1494 1501
12. LaughlinGABarrett-ConnorEBergstromJ 2008 Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93 68 75
13. TivestenAVandenputLLabrieFKarlssonMKLjunggrenO 2009 Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab 94 2482 2488
14. WuFCTajarAPyeSRSilmanAJFinnJD 2008 Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93 2737 2745
15. BogaertVTaesYKoningsPVan SteenKDe BacquerD 2008 Heritability of blood concentrations of sex-steroids in relation to body composition in young adult male siblings. Clin Endocrinol (Oxf) 69 129 135
16. BhasinSCunninghamGRHayesFJMatsumotoAMSnyderPJ 2010 Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95 2536 2559
17. WuFCTajarABeynonJMPyeSRSilmanAJ 2010 Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363 123 135
18. HigginsJPThompsonSGDeeksJJAltmanDG 2003 Measuring inconsistency in meta-analyses. Bmj 327 557 560
19. HaringRIttermannTVolzkeHKrebsAZygmuntM 2010 Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania. Aging Male 13 247 257
20. TravisonTGAraujoABKupelianVO'DonnellABMcKinlayJB 2007 The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92 549 555
21. BasariaSCovielloADTravisonTGStorerTWFarwellWR 2010 Adverse events associated with testosterone administration. N Engl J Med 363 109 122
22. PinosTBarbosa-DesonglesAHurtadoASantamaria-MartinezAde TorresI 2009 Identification, characterization and expression of novel Sex Hormone Binding Globulin alternative first exons in the human prostate. BMC Mol Biol 10 59
23. AhnJSchumacherFRBerndtSIPfeifferRAlbanesD 2009 Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet 18 3749 3757
24. ErikssonALLorentzonMMellstromDVandenputLSwansonC 2006 SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab 91 5029 5037
25. Perry JR, Weedon MN, Langenberg C, Jackson AU, Lyssenko V, et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet 19 535 544
26. HogeveenKNTalikkaMHammondGL 2001 Human sex hormone-binding globulin promoter activity is influenced by a (TAAAA)n repeat element within an Alu sequence. J Biol Chem 276 36383 36390
27. XitaNTsatsoulisAChatzikyriakidouAGeorgiouI 2003 Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels. J Clin Endocrinol Metab 88 5976 5980
28. Martinez-GarayIJablonkaSSutajovaMSteuernagelPGalA 2002 A new gene family (FAM9) of low-copy repeats in Xp22.3 expressed exclusively in testis: implications for recombinations in this region. Genomics 80 259 267
29. OliveiraLMSeminaraSBBeranovaMHayesFJValkenburghSB 2001 The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab 86 1532 1538
30. Pe'erIYelenskyRAltshulerDDalyMJ 2008 Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 32 381 385
31. MazerNA 2009 A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations. Steroids 74 512 519
32. Sinha-HikimIArverSBeallGShenRGuerreroM 1998 The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 83 1312 1318
33. NiemiSMaentaustaOBoltonNJHammondGL 1988 Time-resolved immunofluorometric assay of sex-hormone binding globulin. Clin Chem 34 63 66
34. HammondGLLahteenmakiPL 1983 A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities. Clin Chim Acta 132 101 110
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2011 Číslo 10
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
Najčítanejšie v tomto čísle
- The Glycobiome Reveals Mechanisms of Pentose and Hexose Co-Utilization in Bacteria
- Global Mapping of Cell Type–Specific Open Chromatin by FAIRE-seq Reveals the Regulatory Role of the NFI Family in Adipocyte Differentiation
- Genetic Determinants of Serum Testosterone Concentrations in Men
- MicroRNA Expression and Regulation in Human, Chimpanzee, and Macaque Brains